Related Experiment Videos
Redefining tuberculosis: an interview with Lalita Ramakrishnan.
1Molecular Immunity Unit, Cambridge Institute of Therapeutic Immunology and Infectious Diseases, University of Cambridge, Cambridge CB2 OQH, UK, and MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 OQH, UK.
Disease Models & Mechanisms
|March 23, 2023
Summary
Professor Lalita Ramakrishnan pioneered a zebrafish model for tuberculosis research, revealing crucial host-pathogen interactions. This work informs new treatments for tuberculosis and advances understanding of infectious diseases like leprosy.
Area of Science:
- Microbiology and immunology
- Infectious disease research
- Zebrafish disease models
Background:
- Tuberculosis (TB) remains a significant global health challenge.
- Understanding host-pathogen interactions is key to developing effective treatments.
- Traditional research models have limitations in studying complex infections.
Discussion:
- The development of a robust zebrafish model has revolutionized TB research.
- This model allows for in vivo study of bacterial and host dynamics during infection.
- Professor Ramakrishnan's group has made seminal discoveries using this approach.
Key Insights:
- Uncovered critical bacterial and host interactions throughout TB infection.
- Identified new therapeutic targets and strategies for TB treatment.
- Advanced the fundamental understanding of macrophage biology in infection.
Outlook:
- Potential for developing novel treatments for tuberculosis and other mycobacterial diseases.
- Application of the zebrafish model to study other infectious diseases like leprosy.
- Shaping future clinical research and drug development for TB.